Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
(2018, Current Pharmaceutical Design) characterized BPC-157 as a novel cytoprotective mediator with demonstrated vascular recruitment properties and consistent gastrointestinal tract healing efficacy across acute and chronic injury models
Higher doses, such as 50,000 IU (1,250 mcg), may be recommended in cases of vitamin D deficiency under a doctors guidance
Strongest human evidence The METAOD006 (OPTIONS) Phase 2b trial randomized 502 adults with obesity (BMI 30-45 kg/m^2) to oral AOD-9604 (0.25, 0.5, or 1 mg/day) or placebo for 24 weeks alongside a supervised diet and exercise program
Call our office: (225) 228-3128
US$ 20.02
US$ 29.86
US$ 21.56
US$ 28.53
US$ 22.72
US$ 29.36
US$ 27.69
US$ 29.59
